Clinical Development of HT-100 for Duchenne Has Resumed - PPMD Community: "Phase 1b/2a Clinical Program Resumes Enrollment and Dosing in DMD Patients
Preliminary Clinical Data to be presented at Upcoming Medical Conference "
'via Blog this'
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment